Tracing Metabolic Inflexibility in Fanconi Anemia  - Top-Institutions - MDSpire

Tracing Metabolic Inflexibility in Fanconi Anemia 

Stable-isotope glucose tracing reveals impaired fuel switching and altered energy use in a rare DNA-repair disorder 

  • By

  • Henry Thomas

  • February 10, 2026

  • 11 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatric Hematology
    • Metabolomics
    • Rare Genetic Disorders

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Genetics
    • Hematology
    • Metabolic Research

  • #3

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Biology
    • Genetic Disorders
    • Metabolomics

  • #4

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Genetic Disorders
    • Metabolomics

  • #5

    University of Washington Medical Center
    University of Washington Medical Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Metabolomics
    • Rare Disease Research

Original Source(s)

Tracing Metabolic Inflexibility in Fanconi Anemia 

  • by Henry Thomas

  • February 10, 2026

Related Content

2026 AACR Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
Dana-Farber Researcher Selected to Join the Pew Scholars Program

The Pew Charitable Trusts announced that Xin Gu, PhD, of Dana-Farber Cancer Institute, is among 21 researchers who have been selected to join the Pew Scholars Program in the Biomedical Sciences.

  • by

  • June 18, 2026

  • 2 min
Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

  • June 24, 2026

  • 1 min